Merck Obtains Rights to Drug That Tells the Body It's Full
125992
Merck has obtained rights to license an experimental anti-obesity drug that is based on a hormone the body uses to signal that it has eaten enough.
527417
Some want tighter control of ads, in part to stem overuse of pills.
727152
New developments are brewing at the pharmaceutical.
64799
Merck&#39;s (nyse: MRK - news - people ) decision is based on new three-year data from a clinical trial designed to test the effect of Vioxx on preventing colorectalpolyps.
411592
It makes sense for the drugmaker to sell millions more shares right now.
214430
With its stock plunging, drug giant Merck has adopted a plan that could give top executives big bonuses if the company is taken over.
275812
A computerized pill box that patients can keep at home to dole out their drugs on schedule and in the correct doses received federal approval Thursday.
626150
Merck & Co Inc. won U.S. approval for a new drug to treat a rare and slow-growing skin cancer, health officials said on Friday.
45750
The Food and Drug Administration told Merck &amp; Co. that it would approve the company&#39;s successor drug to the now defunct pain reliever Vioxx if it provides further safety and
35589
The Food and Drug Administration has signed off on the safety of a portion of five (m) million doses that are available from plants in Canada and Germany.
52172
Italian scientists have developed a pill that expands in the stomach to make dieters feel full.
587839
Giving consumers access to cholesterol-lowering drugs without a prescription could expand use of the medicines and help fight the U.S. heart disease epidemic, drugmaker Merck & Co. Inc. told an advisory panel on Thursday.
173007
The Food and Drug Administration told Merck &amp; Co. that it requires further safety and efficacy data before it will approve its successor drug to now defunct pain reliever Vioxx, the pharmaceutical maker announced Friday.
557
TRENTON, N.J. -- A federal court invalidated the patent yesterday for Merck &amp; Co.'s second-largest-selling drug, the blockbuster osteoporosis treatment Fosamax, in a decision that offers millions of patients hope for a cheaper version sooner, but darkens the company's already clouded outlook.
429824
TRENTON, N.J. - Pharmaceutical giant Merck & Co...
734839
Neurocrine resubmits a marketing application for its lead drug.
191337
GlaxoSmithKline won permission yesterday from the Food and Drug Administration to sell a tumor-growth inhibitor called Tykerb to treat breast cancer.